15 July 2022Cannasouth CEO Mark Lucas Interview with Frances CookCannasouth CEO Mark Lucas was invited to participate in an interview with Frances Cook, as part of the Sharesies “Shared Lunch” ...Read More
14 July 2022Cannasouth signs agreement with WEECO PharmaCannasouth has today signed a supplier agreement with WEECO Pharma GmbH based in Germany for the supply of cannabis flower from ...Read More
11 July 2022Rua Bioscience Announcement of Director AppointmentThe Chair of Rua Bioscience Ltd (NZX: RUA), Mr Trevor Burt, and the Rua Board are delighted to announce the appointment ...Read More
30 June 2022Ora Pharm awarded Callaghan Innovation grant for environmentally friendly innovative technologyOra Pharm has been awarded a Callaghan Innovation Grant to develop environmentally friendly, innovative technology for cultivation of medicinal cannabis in ...Read More
29 June 2022Agrify enters highly attractive New Zealand cannabis marketOra Pharm becomes the second international customer to invest in Vertical Farming Units as Agrify continues to gain momentum with its ...Read More
28 June 2022Rua receives narcotic license through Nimbus Health for distribution and marketing of our first product for GermanyRua Bioscience Limited announced today that it has received its narcotic license through Nimbus Health GmbH for distribution and marketing of ...Read More
28 June 2022Greenfern secures lucrative export dealGreenfern Industries has secured a lucrative export deal that could be worth more than NZD$1.6m. Read more ...Read More
22 June 2022Greenfern Industries attains important industry certificationGreenfern Industries Limited is pleased to announce it has attained its globally-recognised GACP (Good Agriculture and Collection Practice) certification for its ...Read More
21 June 2022Cannasouth First Commercial Harvest. Media HighlightsCannasouth recently completed the first commercial harvest from our hybrid, controlled environment cultivation facility. This was a major milestone for us ...Read More
15 June 2022Greenlab joins forces with Helius Therapeutics to develop targeted medicinal cannabis treatmentsNew Zealand-based biotechnology company Greenlab has joined forces with licenced producer Helius Therapeutics to develop specialised and targeted medicinal cannabis treatments ...Read More
26 May 2022GFI sees growth in Australian medical cannabis prescriptionsGreenfern Industries’ GMP medicine prescription sales in the Australian market are going from strength to strength. Read more ...Read More
19 May 2022First products will deliver wider treatment optionsSuccessful assessment by the Medicinal Cannabis Agency of Cannasouth’s first medicinal cannabis products will deliver wider treatment options to New Zealand ...Read More